Bangladesh/Myanmar: Rakhine Conflict 2017 - WHO Situation Report: 07, 16 October 2017

Report
from World Health Organization
Published on 16 Oct 2017 View Original

KEY HIGHLIGHTS

  • As of 15 October 2017, cumulative number of new arrivals in all sites of Bangladesh’s Cox’s Bazar district (Ukiah, Teknaf, Cox’s Bazar and Ramu): 537 000 1 , including 89 000 in host communities, 212 000 in Kutupalong Balukhali camps and 162 000 in new spontaneous sites.

  • The speed and scale of the influx has triggered a humanitarian emergency where close to three quarters of a million displaced people are depending on humanitarian assistance for shelter, food, water, sanitation and other life-saving needs.

  • An oral cholera vaccination campaign launched on 10 October is ongoing, 555 619 people above the age of one year were covered at the end of sixth day. The campaign to administer 900 000 doses of OPV, targets 650 000 people in the first phase.

  • UNICEF and Ministry of Disaster Management and Relief, GoB will construct 10 000 latrines in Rohingya camps and settlements of Cox’s Bazar.

  • Partners are working with GoB to set up WASH facilities (pit latrines, de-sludge facilities and production wells) in the new camps.

  • E. coli testing of household water samples in Leda makeshift settlement found that they meet Bangladesh and WHO standards of E. coli (<1 cfu/100ml).

  • Field visit to Chakmarkul Spontaneous Settlement and Upazila Health Complex, Teknaf highlighted gaps in WASH services, food and nutrition and health post function.

SITUATION OVERVIEW

Oral cholera vaccination (OCV) campaign

555 619 people vaccinated at the end of the 6th day: A total of 150 teams deployed in Ukhiya, 60 teams in Teknaf and 20 teams in Naikhangchari have successfully administered OCV to 84% of the total estimated target population. Rapid coverage assessments showed 92% of those assessed had received the vaccine. Good momentum has been achieved with many initial gaps addressed with help of partners. So far no cases of Adverse Effects Following Immunization (AEFI) have been noted.